Feasibility Testing of the Alert for Atrial Fibrillation Program
NCT ID: NCT01988974
Last Updated: 2017-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2013-11-30
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
NCT00578617
A Study of a Lifestyle Program on Recurrent Atrial Fibrillation
NCT06155357
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
NCT06783868
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
NCT06200311
COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation
NCT02997254
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alert for AF Program
1\) participation in the Alert for Atrial Fibrillation program ) .
Alert for Atrial Fibrillation Program
Participants' baseline knowledge of AF symptoms, and attitudes and beliefs about AF will be assessed using the KABAFS, and patients will receive cognitive-behavioral training directed toward survey responses associated with delay of treatment. Training will incorporate the content developed by the American College of Cardiology Foundation (ACCF), and participants will receive education about how to recognize an irregular pulse, and how to record the pulse rhythm in a daily log. The PI/RN coordinator will review the completed KABAFS to assess knowledge deficits, and identify attitudes and beliefs about AF that may hinder early treatment-seeking.
Attention control condition
2\) participation in the healthy sleep program
Healthy Sleep
Participants will receive a 45 minute face to face instruction about sleep hygiene
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alert for Atrial Fibrillation Program
Participants' baseline knowledge of AF symptoms, and attitudes and beliefs about AF will be assessed using the KABAFS, and patients will receive cognitive-behavioral training directed toward survey responses associated with delay of treatment. Training will incorporate the content developed by the American College of Cardiology Foundation (ACCF), and participants will receive education about how to recognize an irregular pulse, and how to record the pulse rhythm in a daily log. The PI/RN coordinator will review the completed KABAFS to assess knowledge deficits, and identify attitudes and beliefs about AF that may hinder early treatment-seeking.
Healthy Sleep
Participants will receive a 45 minute face to face instruction about sleep hygiene
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Under the care of providers from the Department of Medicine
* English-speaking
* Community dwelling,
* Have access to and ability to communicate via a telephone
* Have one or more risks for developing AF
* Not be diagnosed with AF
Exclusion Criteria
* Uncompensated hearing or visual deficits
* Scheduled for surgery or have undergone a surgical procedure in the last 30 days,
* Undergoing active treatment for a malignancy
* Receiving hospice care will be excluded
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pamela J. McCabe, R.N., Ph.D.
Assistant Professor of Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pamela J McCabe, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-007768
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.